Sumatriptan Succinate
Product Images NDC 66116-413
Product Visual Gallery
This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Sumatriptan Succinate (NDC 66116-413). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Medvantx, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Figure 1: Estimated Probability Of Achieving Initial Headache Response Within 240 Minutes* (2fbc01fb B787 4ff1 Bb9f 280dfe975531 02)
Figure 2: The Estimated Probability Of Patients Taking A Second Dose Or Other Medication For Migraine Over The 24 Hours Following The Initial Dose Of Study Treatment* (2fbc01fb B787 4ff1 Bb9f 280dfe975531 03)
Sumatriptan Succinate Tablets 50mg (2fbc01fb B787 4ff1 Bb9f 280dfe975531 04)
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.